These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 37537279)

  • 21. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Brain Science on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome].
    Watanabe Y
    Brain Nerve; 2018 Nov; 70(11):1193-1201. PubMed ID: 30416112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomic Evidence for Peroxisomal Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Che X; Brydges CR; Yu Y; Price A; Joshi S; Roy A; Lee B; Barupal DK; Cheng A; Palmer DM; Levine S; Peterson DL; Vernon SD; Bateman L; Hornig M; Montoya JG; Komaroff AL; Fiehn O; Lipkin WI
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of Gender Differences in HRV of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Mobile-Health Technology.
    Capdevila L; Castro-Marrero J; Alegre J; Ramos-Castro J; Escorihuela RM
    Sensors (Basel); 2021 May; 21(11):. PubMed ID: 34071326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient perceptions of infectious illnesses preceding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Jason LA; Yoo S; Bhatia S
    Chronic Illn; 2022 Dec; 18(4):901-910. PubMed ID: 34541918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal Resting-State Functional Connectivity in Patients with Chronic Fatigue Syndrome: Results of Seed and Data-Driven Analyses.
    Gay CW; Robinson ME; Lai S; O'Shea A; Craggs JG; Price DD; Staud R
    Brain Connect; 2016 Feb; 6(1):48-56. PubMed ID: 26449441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
    Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
    J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
    Domingo JC; Cordobilla B; Ferrer R; Giralt M; Alegre-Martín J; Castro-Marrero J
    Antioxid Redox Signal; 2021 Jun; 34(18):1420-1427. PubMed ID: 33353469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis.
    Du Preez S; Corbitt M; Cabanas H; Eaton N; Staines D; Marshall-Gradisnik S
    Syst Rev; 2018 Dec; 7(1):241. PubMed ID: 30572962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Petter E; Scheibenbogen C; Linz P; Stehning C; Wirth K; Kuehne T; Kelm M
    J Transl Med; 2022 Dec; 20(1):580. PubMed ID: 36494667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S
    Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between prior psychiatric disorder and chronic fatigue: evidence from a national birth cohort study.
    Harvey SB; Wadsworth M; Wessely S; Hotopf M
    Psychol Med; 2008 Jul; 38(7):933-40. PubMed ID: 17976252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus?
    Hatziagelaki E; Adamaki M; Tsilioni I; Dimitriadis G; Theoharides TC
    J Pharmacol Exp Ther; 2018 Oct; 367(1):155-167. PubMed ID: 30076265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing severity of illness and outcomes of treatment in children with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME): a systematic review of patient-reported outcome measures (PROMs).
    Haywood KL; Collin SM; Crawley E
    Child Care Health Dev; 2014 Nov; 40(6):806-24. PubMed ID: 24661148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion tensor imaging reveals neuronal microstructural changes in myalgic encephalomyelitis/chronic fatigue syndrome.
    Thapaliya K; Marshall-Gradisnik S; Staines D; Barnden L
    Eur J Neurosci; 2021 Sep; 54(6):6214-6228. PubMed ID: 34355438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Illness progression in chronic fatigue syndrome: a shifting immune baseline.
    Russell L; Broderick G; Taylor R; Fernandes H; Harvey J; Barnes Z; Smylie A; Collado F; Balbin EG; Katz BZ; Klimas NG; Fletcher MA
    BMC Immunol; 2016 Mar; 17():3. PubMed ID: 26965484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms.
    Jonsjö MA; Olsson GL; Wicksell RK; Alving K; Holmström L; Andreasson A
    Psychoneuroendocrinology; 2020 Mar; 113():104578. PubMed ID: 31901625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
    J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine network analysis in a community-based pediatric sample of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Jason LA; Gaglio CL; Furst J; Islam M; Sorenson M; Conroy KE; Katz BZ
    Chronic Illn; 2023 Sep; 19(3):571-580. PubMed ID: 35570777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.